iSpecimen Inc. (ISPC) stock

ISPCNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 7/3032% below fair value

$0.66−0.04 (-5.43%)

Close on Nov 13, 2026Market cap $1.66MP/E –Yield –

iSpecimen operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

iSpecimen's operating cash flow for the twelve months ending Jun 30, 2026 was -$7.00M. For fiscal 2025 it was -$4.24M. The highest annual figure on record is -$288.38K in fiscal 2020.

Annual operating cash flow

Period	Period end	Value	Change
FY2025	Dec 31, 2025	-$4.24M	–
FY2024	Dec 31, 2024	-$8.26M	–
FY2023	Dec 31, 2023	-$5.81M	–
FY2022	Dec 31, 2022	-$5.82M	–
FY2021	Dec 31, 2021	-$10.67M	–
FY2020	Dec 31, 2020	-$288.38K	–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q2 FY2026	Jun 30, 2026	-$689.63K	–
Q1 FY2026	Mar 31, 2026	-$3.36M	–
Q4 FY2025	Dec 31, 2025	-$916.92K	–
Q3 FY2025	Sep 30, 2025	-$2.04M	–
Q2 FY2025	Jun 30, 2025	-$192.23K	–
Q1 FY2025	Mar 31, 2025	-$1.10M	–
Q4 FY2024	Dec 31, 2024	-$3.57M	-1135.1%
Q3 FY2024	Sep 30, 2024	-$1.08M	–
Q2 FY2024	Jun 30, 2024	-$1.54M	–
Q1 FY2024	Mar 31, 2024	-$2.07M	–
Q4 FY2023	Dec 31, 2023	$345.14K	–
Q3 FY2023	Sep 30, 2023	-$1.63M	–
Q2 FY2023	Jun 30, 2023	-$1.69M	–
Q1 FY2023	Mar 31, 2023	-$2.83M	–
Q4 FY2022	Dec 31, 2022	-$207.35K	–
Q3 FY2022	Sep 30, 2022	-$2.26M	–
Q2 FY2022	Jun 30, 2022	-$1.98M	–
Q1 FY2022	Mar 31, 2022	-$1.38M	–
Q4 FY2021	Dec 31, 2021	-$1.32M	–
Q3 FY2021	Sep 30, 2021	-$6.08M	–
Q2 FY2021	Jun 30, 2021	-$3.14M	–
Q1 FY2021	Mar 31, 2021	-$126.25K	–
Q4 FY2020	Dec 31, 2020	-$24.65K	–
Q3 FY2020	Sep 30, 2020	-$319.41K	–